Acetazolamide Withdrawn Phase 2 Trials for Bacterial Infection Due to Helicobacter Pylori (H. Pylori) Treatment

IndicationsStatusPurposePhase
WithdrawnTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT02090738A Randomized, Open-label Study on Helicobacter Pylori Eradication With Standard Triple Regimen Plus Acetazolamide